Skip to main content

Advertisement

Log in

The Management of Lymphoma in the Setting of Pregnancy

  • B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (D Persky, Section Editor)
  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

The diagnosis of lymphoma in pregnant patients poses a therapeutic challenge necessitating consideration of the developing fetus without compromise of therapy with curative potential for the mother. The decision to initiate therapy during pregnancy is heavily influenced by fetal, maternal, and disease-related factors, of which the most influential are the trimester at diagnosis, the stage, and aggressiveness of the disease and the presence of life-threatening symptoms. Recent data suggest that deferral of therapy until after the first trimester is desirable if it is perceived that postponement of therapy will not compromise maternal outcome. For some patients, delay of therapy to the postpartum period is feasible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279–87.

    Article  PubMed  Google Scholar 

  2. Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28:683–9.

    Article  PubMed  Google Scholar 

  3. Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015;373:1824–34.

    Article  CAS  PubMed  Google Scholar 

  4. Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med. 2010;363:640–52.

    Article  CAS  PubMed  Google Scholar 

  5. Woitek R, Prayer D, Hojreh A, Helbich T. Radiological staging in pregnant patients with cancer. ESMO Open. 2016;1:e000017.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Okuda Y, Sagami F, Tirone P, et al. Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)--study of embryo-fetal toxicity in rabbits by intravenous administration. J Toxicol Sci. 1999;24(Suppl 1):79–87.

    Article  CAS  PubMed  Google Scholar 

  7. Kennedy EV, Iball GR, Brettle DS. Investigation into the effects of lead shielding for fetal dose reduction in CT pulmonary angiography. Br J Radiol. 2007;80:631–8.

    Article  CAS  PubMed  Google Scholar 

  8. • Rimawi BH, Green V, Lindsay M. Fetal implications of diagnostic radiation exposure during pregnancy: evidence-based recommendations. Clin Obstet Gynecol. 2016;59:412–8. Evidence-based recommendations for diagnostic radiographic studies during pregnancy with concise review of radiation doses associated with fetal risk as well as radiation doses from standard radiological studies

    Article  PubMed  Google Scholar 

  9. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16:347–68.

    CAS  PubMed  Google Scholar 

  10. Martin DD. Review of radiation therapy in the pregnant cancer patient. Clin Obstet Gynecol. 2011;54:591–601.

    Article  PubMed  Google Scholar 

  11. Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13:887–96.

    Article  CAS  PubMed  Google Scholar 

  12. Abdel-Hady el S, Hemida RA, Gamal A, et al. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet. 2012;286:283–6.

  13. •• Evens AM, Advani R, Press OW, et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol. 2013;31:4132–9. Largest multi-institutional study of 90 patients with lymphoma diagnosed during pregnancy. There was no significant difference in maternal or fetal complications between the women that received antenatal therapy as compared to those who had treatment deferred to the postpartum period. No patient received treatment during the first trimester of pregnancy

    Article  PubMed  Google Scholar 

  14. •• Pinnix CC, Osborne EM, Chihara D, et al. Maternal and fetal outcomes after therapy for Hodgkin or non-Hodgkin lymphoma diagnosed during pregnancy. JAMA Oncol. 2016;2:1065–9. Single institutional study of 39 patients diagnosed with lymphoma while pregnant at MDACC. There was no statistically significant difference in maternal outcome according to receipt of antenatal therapy. Four miscarriages occurred, all among patients treated during pregnancy, with 2 of the 4 occurring in patients that receive first trimester therapy

    Article  PubMed  Google Scholar 

  15. • Avivi I, Farbstein D, Brenner B, Horowitz NA. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. Blood Rev. 2014;28:213–20. Case-based review of the diagnostic and therapeutic challenges of NHL diagnosed during pregnancy

    Article  PubMed  Google Scholar 

  16. Bachanova V, Connors JM. Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep. 2013;8:211–7.

    Article  PubMed  Google Scholar 

  17. Hodgson DC, Mikhaeel NG. Consolidative radiation in DLBCL: Evidence-based recommendations. Curr Oncol Rep. 2015;17:49.

    Article  PubMed  Google Scholar 

  18. Ng AK, Dabaja BS, Hoppe RT, et al. Re-examining the role of radiation therapy for diffuse large B-cell lymphoma in the modern era. J Clin Oncol. 2016;34:1443–7.

    Article  CAS  PubMed  Google Scholar 

  19. Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin’s disease. Med Dosim. 1997;22:135–7.

    Article  CAS  PubMed  Google Scholar 

  20. Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol. 2003;66:333–9.

    Article  PubMed  Google Scholar 

  21. Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1992;23:407–12.

    Article  CAS  PubMed  Google Scholar 

  22. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117:1499–506.

    Article  CAS  PubMed  Google Scholar 

  23. Mandal PK, Dolai TK, Bagchi B, et al. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen. Indian J Pediatr. 2014;81:1092–4.

    Article  PubMed  Google Scholar 

  24. Burnette BL, Jentoft MA, Porrata LF, et al. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. J Clin Oncol. 2014;32:e14–7.

    Article  PubMed  PubMed Central  Google Scholar 

  25. •• Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13:256–64. Multicenter case-control study of 129 children born to mothers diagnosed with cancer during pregnancy matched to children of mothers without cancer. Gestational age at the time of delivery (i.e., prematurity) was associated with inferior cognitive outcome in both groups. There was no adverse effect of antenatal therapy detected in this study

    Article  CAS  PubMed  Google Scholar 

  26. Maternal Cancer During Pregnancy and Risks of Stillbirth and Infant Mortality. Lu D, Ludvigsson JF, Smedby KE, Fall K, Valdimarsdóttir U, Cnattingius S, Fang F. J Clin Oncol. 2017 Mar 6:JCO2016699439. doi:10.1200/JCO.2016.69.9439. [Epub ahead of print] PMID: 28384079

  27. Weibull CE, Eloranta S, Smedby KE, et al. Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma. J Clin Oncol. 2016;34:337–44.

    Article  PubMed  Google Scholar 

  28. Amant F, Verheecke M, Wlodarska I, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015;1:814–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chelsea C Pinnix.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on B-cell NHL, T-cell NHL, and Hodgkin Lymphoma

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinnix, C.C., Andraos, T.Y., Milgrom, S. et al. The Management of Lymphoma in the Setting of Pregnancy. Curr Hematol Malig Rep 12, 251–256 (2017). https://doi.org/10.1007/s11899-017-0386-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-017-0386-x

Keywords

Navigation